TY - JOUR
T1 - Applying the Monod-Wyman-Changeux allosteric activation model to pseudo–steady-state responses from GABAA receptors
AU - Steinbach, Joe Henry
AU - Akk, Gustav
N1 - Publisher Copyright:
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics
PY - 2019/1
Y1 - 2019/1
N2 - The Monod-Wyman-Changeux (MWC) cyclic model was described as a kinetic scheme to explain enzyme function and modulation more than 50 years ago and was proposed as a model for understanding the activation of transmitter-gated channels soon afterward. More recently, the MWC model has been used to describe the activation of the GABAA receptor by the transmitter, GABA, and drugs that bind to separate sites on the receptor. It is most interesting that the MWC formalism can also describe the interactions among drugs that activate the receptor. In this review, we describe properties of the MWC model that have been explored experimentally using the GABAA receptor, summarize analytical expressions for activation and interaction for drugs, and briefly review experimental results.
AB - The Monod-Wyman-Changeux (MWC) cyclic model was described as a kinetic scheme to explain enzyme function and modulation more than 50 years ago and was proposed as a model for understanding the activation of transmitter-gated channels soon afterward. More recently, the MWC model has been used to describe the activation of the GABAA receptor by the transmitter, GABA, and drugs that bind to separate sites on the receptor. It is most interesting that the MWC formalism can also describe the interactions among drugs that activate the receptor. In this review, we describe properties of the MWC model that have been explored experimentally using the GABAA receptor, summarize analytical expressions for activation and interaction for drugs, and briefly review experimental results.
UR - http://www.scopus.com/inward/record.url?scp=85057864108&partnerID=8YFLogxK
U2 - 10.1124/mol.118.113787
DO - 10.1124/mol.118.113787
M3 - Article
C2 - 30333132
AN - SCOPUS:85057864108
SN - 0026-895X
VL - 95
SP - 106
EP - 119
JO - Molecular pharmacology
JF - Molecular pharmacology
IS - 1
ER -